U.S. District Judge Rebecca Doherty, who is overseeing the Actos Products Liability multidistrict litigation in U.S. District Court for the Western District of Louisiana ,has issued a direct filing order for all new Actos lawsuits, which will allow new plaintiffs to join the MDL directly instead of filing Actos lawsuits in local courts and having to wait for it to be transferred to the Lafayette federal court.
As many as 10,000 lawsuits could be filed against Takeda Pharmaceuticals over allegations that the type 2 diabetes drug Actos has patients to develop bladder cancer, Bloomberg reported. Last year, the U.S. Food and Drug Administration issued a warning that long-term or high dose Actos users face a 40 percent increase in developing bladder cancer. Health Canada has also issued a warning concerning the drug, and the drug is currently banned in Germany and France.
Actos has also been linked to increased heart disease and cardiovascular risks, and a study published in the Journal of Clinical Endocrinology & Metabolism linked the drug to an increased risk of fracture in postmenopausal women, and in men who were also prescribed a loop diuretic.